Russia’s RDIF and Sberbank Launch $100m Start-Up Fund
Duo To Seed New Russian-Based Tech And Science Start-Ups
Russian sovereign wealth fund and Sputnik V vaccine producer RDIF has teamed up with the country’s biggest bank to fund ‘home-grown’ tech and science-intensive start-ups.
You may also be interested in...
Global research consortium to investigate the use of immunoglobulin as a COVID-19 therapy ends following disappointing results from a Phase III trial. Meanwhile, Russian vaccine producer RDIF is snapping up more production capacity in India, where interferon has also progressed as a possible treatment.
Members of the European Parliament heard from top EU officials on initiatives being undertaken to strengthen the provision of coronavirus vaccines as member states try to deal with a surge in COVID-19 cases.
Emerging Company Profile: Privately held BioPlx is a US-based platform biotech that has successfully raised more than $10m from investors with the promise of developing non-antibiotic ways to control multiple-drug resistant superbugs and other infectious diseases.